The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Sumitomo Dainippon’s Napabucasin Stumbles on PIII Gastric Cancer Study
June 27, 2017
-
BUSINESS Daiichi Sankyo Confident of Achieving US$1 Billion Sales for Edoxaban
June 26, 2017
-
REGULATORY Wakayama Substance Supplier Mixed in China-Made Ingredient; MHLW Sees No Safety Concerns
June 23, 2017
-
BUSINESS Development Race Heating Up for HIF-PH Inhibitors, Promising Alternative to ESAs in Renal Anemia Space?
June 22, 2017
-
BUSINESS Amgen Astellas Biopharma Gearing Up for 2020 Takeoff as Stand-Alone Subsidiary
June 20, 2017
-
ORGANIZATION FPMAJ Calls for Maintaining Prices for On-Patent Drugs, Lower Price Reduction Rates in Off-Year Revisions
June 19, 2017
-
BUSINESS Biogen Japan Upbeat on Tecfidera, Near-Approval Nusinersen, Sakigake Boost for Aducanumab
June 19, 2017
-
TRENDS Authorized Generics Solidifying Their Presence in Japan Gx Market
June 16, 2017
-
REGULATORY 1st Generics for 13 APIs to Join NHI Price List on June 16; Micardis, Abilify Face Competition
June 15, 2017
-
REGULATORY (Update) Add’l Eligibility Criteria Proposed for Companies to Get Price Maintenance Premium, Tiered Premiums Eyed: Chuikyo
June 15, 2017
-
REGULATORY Add’l Eligibility Criteria Proposed for Companies to Get Price Maintenance Premium: Chuikyo
June 14, 2017
-
ACADEMIA Japanese Society of Hypertension to Verify Results of SPRINT Study
June 14, 2017
-
ORGANIZATION JGA Appreciates Tweaked Honebuto Text on Generics, 80% Goal Achievable on Production Basis
June 13, 2017
-
REGULATORY Govt’s Regulatory Reform Plan Embraces Review of 14-Day Prescription Limit
June 12, 2017
-
REGULATORY Japan Cabinet Adopts 2017 Honebuto Policy
June 12, 2017
-
ORGANIZATION JMA’s Nakagawa Questions Price Difference for LLPs and AGs, Negative about PhRMA Pitch for AWP Alternatives
June 9, 2017
-
BUSINESS FDA Accepts Sawai’s ANDA for Tecfidera Generic
June 8, 2017
-
BUSINESS Pfizer Boosting Global Oncology Footprint with Diverse Portfolio: SVP
June 7, 2017
-
BUSINESS Discontinuation of Development Continues for Novel Diabetes Drugs, Including Daiichi Sankyo’s GPR119 Agonist
June 6, 2017
-
BUSINESS AbbVie to Seek Indication Expansions for Humira, Competing with Biosimilars on the Strength of Original Product’s Reliability
June 5, 2017
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…